HKEX Stock Code: 01093English|繁體|简体

Highlight - 1H2023

Revenue
RMB16,080mn, +3.0%
Underlying profit attributable to shareholders
RMB3,162mn, +3.0%
Profit attributable to shareholders
RMB2,967mn, +0.0%
Basic earnings per share
RMB24.95 cents, +0.2%

Key Products

Finished drugs
Bulk drugs
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.